Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
1 other identifier
interventional
840
1 country
1
Brief Summary
The investigators propose to conduct a combined intervention that pairs SMS smoking cessation messages for patients with individualized training for OB clinicians to improve quit rates among pregnant smoking. The aim is to determine the effect of the intervention versus control on smoking cessation outcomes on patient smoking cessation. The investigators will recruit patients at their first OB visit who report smoking at Duke and Pitt. Patients in both the control and intervention arm will receive smoking cessation support messages throughout their pregnancy. OB clinicians in the intervention arm will receive tailored smoking cessation counseling training. Clinicians in both arms will receive a one-time 5 A lecture. The investigators will analyze smoking cessation outcomes and audio recordings. This is a minimal risk study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2021
CompletedFirst Posted
Study publicly available on registry
August 2, 2021
CompletedStudy Start
First participant enrolled
March 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
April 22, 2026
April 1, 2026
4.2 years
July 22, 2021
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Patients in the Post-Intervention Phase With Validated Cessation
Biochemically validated (urine cotinine) 7-day point prevalent as defined by urine cotinine levels below 50ng/ML.
End-of-pregnancy, up to 45 minutes
Secondary Outcomes (2)
Number of A's performed in the Post-Intervention Phase for each Clinician
Post-intervention recordings (all recording will happen prior to giving birth), up to 12 weeks
Mean rated autonomy support for each Post-intervention patient
Baseline, up to 15 minutes
Study Arms (2)
Intervention
EXPERIMENTALClinicians in the intervention arm will receive a tailored communication training on smoking cessation skills and a general lecture on smoking cessation.
Control
ACTIVE COMPARATORClinicians in the control arm will be asked to attend a lecture on general information about smoking cessation for pregnant patients and smoking cessation counseling.
Interventions
The focus of the communication program is to help clinicians increase their use of the 5 A's by improving knowledge, self-efficacy, outcome expectations, and communication skills. Training modules include didactic information with video clips of sample conversations showing specific communication skills, feedback on clinician's usage of the 5A's, and audio clips from their Pre-Intervention recorded conversations.
a lecture on general information about smoking cessation for pregnant patients and smoking cessation counseling.
Eligibility Criteria
You may qualify if:
- ≥18 years old
- Receiving prenatal care from an enrolled OB clinician
- Self-report smoking tobacco at their first OB visit
- Access to a cell phone with texting capabilities
You may not qualify if:
- Unable to speak and read English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- University of Pittsburghcollaborator
Study Sites (1)
Durham OB
Durham, North Carolina, 27704, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathryn I Pollak, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- We will mask the intervention arms during the coding process.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2021
First Posted
August 2, 2021
Study Start
March 25, 2022
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
April 22, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share